Abstract
Low Rates of Documented Infection in Patients with Acute Myeloid Leukemia (AML) Receiving Venetoclax + Hypomethylating Agents (VEN-HMA)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have